logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Milligan, Claire Lisa
    Born in November 1971
    Individual (3 offsprings)
    Officer
    icon of calendar 2016-01-15 ~ now
    OF - Director → CIF 0
    Mrs Claire Lisa Milligan
    Born in November 1971
    Individual (3 offsprings)
    Person with significant control
    icon of calendar 2017-01-14 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
parent relation
Company in focus

CLAIRE DAVIES PHARMA CONSULTING LIMITED

Standard Industrial Classification
70229 - Management Consultancy Activities Other Than Financial Management
Brief company account
Par Value of Share
Class 1 ordinary share
12024-02-01 ~ 2025-01-31
Property, Plant & Equipment
45,474 GBP2025-01-31
57,559 GBP2024-01-31
Total Inventories
7,650 GBP2024-01-31
Debtors
28,627 GBP2025-01-31
974 GBP2024-01-31
Cash at bank and in hand
352,201 GBP2025-01-31
126,441 GBP2024-01-31
Current Assets
380,828 GBP2025-01-31
135,065 GBP2024-01-31
Creditors
Current
91,580 GBP2025-01-31
7,832 GBP2024-01-31
Net Current Assets/Liabilities
289,248 GBP2025-01-31
127,233 GBP2024-01-31
Total Assets Less Current Liabilities
334,722 GBP2025-01-31
184,792 GBP2024-01-31
Net Assets/Liabilities
327,094 GBP2025-01-31
175,933 GBP2024-01-31
Equity
Called up share capital
100 GBP2025-01-31
100 GBP2024-01-31
Retained earnings (accumulated losses)
326,994 GBP2025-01-31
175,833 GBP2024-01-31
Equity
327,094 GBP2025-01-31
175,933 GBP2024-01-31
Average Number of Employees
12024-02-01 ~ 2025-01-31
12023-02-01 ~ 2024-01-31
Property, Plant & Equipment - Gross Cost
Improvements to leasehold property
55,270 GBP2025-01-31
55,270 GBP2024-01-31
Plant and equipment
499 GBP2025-01-31
499 GBP2024-01-31
Furniture and fittings
6,297 GBP2025-01-31
6,297 GBP2024-01-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Improvements to leasehold property
49,999 GBP2025-01-31
44,472 GBP2024-01-31
Plant and equipment
188 GBP2025-01-31
134 GBP2024-01-31
Furniture and fittings
4,846 GBP2025-01-31
4,591 GBP2024-01-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Improvements to leasehold property
5,527 GBP2024-02-01 ~ 2025-01-31
Plant and equipment
54 GBP2024-02-01 ~ 2025-01-31
Furniture and fittings
255 GBP2024-02-01 ~ 2025-01-31
Property, Plant & Equipment
Improvements to leasehold property
5,271 GBP2025-01-31
Plant and equipment
311 GBP2025-01-31
Furniture and fittings
1,451 GBP2025-01-31
Property, Plant & Equipment - Gross Cost
Motor vehicles
56,090 GBP2025-01-31
56,090 GBP2024-01-31
Computers
3,131 GBP2025-01-31
3,633 GBP2024-01-31
Property, Plant & Equipment - Gross Cost
121,287 GBP2025-01-31
121,789 GBP2024-01-31
Property, Plant & Equipment - Disposals
Computers
-1,418 GBP2024-02-01 ~ 2025-01-31
Property, Plant & Equipment - Disposals
-1,418 GBP2024-02-01 ~ 2025-01-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Motor vehicles
19,645 GBP2025-01-31
13,214 GBP2024-01-31
Computers
1,135 GBP2025-01-31
1,770 GBP2024-01-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
75,813 GBP2025-01-31
64,181 GBP2024-01-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Motor vehicles
6,431 GBP2024-02-01 ~ 2025-01-31
Computers
783 GBP2024-02-01 ~ 2025-01-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
13,050 GBP2024-02-01 ~ 2025-01-31
Property, Plant & Equipment - Decrease in depreciation and impairment related to disposals
Computers
-1,418 GBP2024-02-01 ~ 2025-01-31
Property, Plant & Equipment - Decrease in depreciation and impairment related to disposals
-1,418 GBP2024-02-01 ~ 2025-01-31
Property, Plant & Equipment
Motor vehicles
36,445 GBP2025-01-31
Computers
1,996 GBP2025-01-31
Value of work in progress
7,650 GBP2024-01-31
Amount of corporation tax that is recoverable
Current
329 GBP2025-01-31
Prepayments/Accrued Income
Current
26,994 GBP2025-01-31
Debtors
Amounts falling due within one year, Current
28,627 GBP2025-01-31
Current, Amounts falling due within one year
974 GBP2024-01-31
Trade Creditors/Trade Payables
Current
90 GBP2024-01-31
Corporation Tax Payable
Current
66,297 GBP2025-01-31
3,246 GBP2024-01-31
Other Taxation & Social Security Payable
Current
163 GBP2025-01-31
162 GBP2024-01-31
Other Creditors
Current
6 GBP2025-01-31
Accrued Liabilities
Current
915 GBP2025-01-31
790 GBP2024-01-31
Amounts set aside to cover potential liabilities or losses
Deferred taxation
7,628 GBP2025-01-31
8,859 GBP2024-01-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
100 shares2025-01-31
  • CLAIRE DAVIES PHARMA CONSULTING LIMITED
    Info
    Registered number 09953150
    icon of address45 Queen Street, Deal, Kent CT14 6EY
    PRIVATE LIMITED COMPANY incorporated on 2016-01-15 (9 years 11 months). The company status is Active.
    The last date of confirmation statement was made at 2025-01-14
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.